期刊文献+

移植肾穿刺活检60例的病理学研究 被引量:2

Pathological analysis of 60 cases of renal allograft biopsy
暂未订购
导出
摘要 目的研究移植肾在术后出现合并症时,经皮肾穿刺活检的病理形态学特点,探讨穿刺活检的诊断意义。方法参照Banff 2005和Banff 1997移植肾活检病理学诊断与分类方案对60例移植肾的穿刺活检标本进行病理学诊断和分类。结果 60例移植肾穿刺活检标本中急性排斥反应17例(28.3%)、慢性排斥反应21例(35.0%)、界线性病变9例(15.0%)、复发或新发性肾病6例(10.0%),急性肾小管损伤5例(8.3%)、药物毒性反应2例(3.3%)。结论移植肾穿刺活检的病理学观察可以及时准确地诊断肾移植术后的多种合并症,是一种安全有效的诊断手段。 Objective To investigate the pathological changes of renal allografts through percutaneous renal biopsy when complications happened after the kidney transplant.Methods Speciments of 60 cases of percutaneous renal biopsy were pathological diagnosed and classified according to Banff 2005 and Banff 1997 standards.Results 17 of 60 allografts demonstrated acute rejection.21 cases showed chronic rejection.Borderline changes were found in 9 of 60 cases.Recurrent or de novo diseases were seen in 6 cases.5 cases showed acute nephric tubule damage and 2 cases demonstrated secondary reaction to drug toxicity.Conclusion Pathological observation throught percutaneous renal biopsy after the kidney transplant may be helpful in making the prompt and accurate diagnosis of multiple transplant complications.It is a safe and effective diagnosis approach.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第1期50-52,共3页 Acta Universitatis Medicinalis Anhui
基金 陕西省科技计划项目(编号:2009K17-04)
关键词 肾移植 活检 病理诊断 kidney transplantatiotion biopsy pathological diagnosis
  • 相关文献

参考文献10

  • 1王磊,王珏,付强,等.慢性肾功能衰竭的治疗现状及研究前景[J].现代生物学进展,2012,12(10) :1983 -5.
  • 2Kozakjowski N, Regele H. Biopsy diagnostics in renal allograft re-jection: from histomorpphology to biological fuction [ J ]. Trans-plant International, 2009,22(10) :945 -53.
  • 3Solez K, Colvin R, Recusen L C,et al. Banfff05 meeting report:differential diagnosis of chronic allograft injury and elimination ofchronic allograft nephropathy ( ‘ CAN ’ ) [ J ]. Am J Transplant,2007,7(3) :518 -26.
  • 4徐林,黄陵.人类异体肾移植体液排斥反应的病理形态学及发病机理的探讨[J].中华病理学杂志,1991,20(2):143-144. 被引量:18
  • 5Colvin R B. The renal allograft biopsy [ J]. Kidney Int, 1996 , 50(3):1069 -82.
  • 6Gaber L W,Moore L W, Gaber A 0,et al. Correlation of histolo-gy to clinical rejection reversal : A thymoglobulin multicenter trialreport [J]. Kidney Int, 1999,55(6) :2415 -22.
  • 7Fisher J S, Woodle E S,Thistlethwaite Jr J R. Kidney transplan-tation :Graft monitoring and immunosuppression [ J]. World Surg,2002,26(2) :185 -93.
  • 8吴珊,王医术,周洪澜,姜云鹏,朱桂彬,傅耀文.移植肾功能减退60例穿刺活检病理形态研究[J].中华病理学杂志,2007,36(3):199-200. 被引量:2
  • 9Collins A B,Schneeberger E E, Pascual M A, et al. Compiementactivation in acute humoral renal allograft rejection: diagnostic sig-nicance of C4d deposits in peritubular capillaries [ J ]. J Am SocNephrol, 1999, 10(10) : 2208 -14.
  • 10曹正国,诸禹平,曾凡军,周四维,刘继红,林正斌,亓林,吴奎.肾移植术后早期无尿或少尿的诊治[J].安徽医科大学学报,2006,41(4). 被引量:1

二级参考文献12

  • 1黄受方,中华病理学杂志,1988年,17卷,19页
  • 2李维华,中华病理学杂志,1982年,11卷,19页
  • 3Browne B J, Holt C O, Emovon O E. Delayed graft function may not adversely affect short-term renal allograft outcome [ J ]. Clin Transplant, 2003, 17 (S9) :35 - 8.
  • 4Nankivell B J, Fenton-Lee C A, Kuypers D R, et al. Effect of histological damage on long-term kidney transplant outcome [ J ].Transplantation, 2001, 71 (4) :515 -23.
  • 5Chang G J, Mahanty H D,Vincenti F, et al. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function [ J ].Clin Transplant, 2000, 14 (6) :550 -4.
  • 6Racusen LC,Solez K,Colvin RB,et al.The Banff 97 working classification of renal allograft pathology.Kidney Int,1999,55(2):713-723.
  • 7Racusen LC,Colvin RB,Solez K,et al.Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft refection.Am J Transplant,2003,3(6):708-714.
  • 8黄受方.肾移植病理学//夏同礼.现代泌尿病理学.北京:人民卫生出版社,2002:67-93.
  • 9章友康.泌尿系统疾病/叶任高.内科学.5版.北京:人民卫生出版社,2000:513-520.
  • 10陈惠萍,曾彩虹,尹广,殷立平,王建平,黎磊石.移植后慢性肾损害的病理及临床分析[J].肾脏病与透析肾移植杂志,2000,9(1):9-12. 被引量:17

共引文献18

同被引文献18

  • 1贾住.移植肾病理对肾移植临床指导意义的研究[D].复旦大学,2009.
  • 2Matas AJ. Recurrent disease after kidney transplantation-- it is time to unite to address this problem! [J]. Am J Transplant, 2006,6(11) : 2527-2528.
  • 3Racusen LC, Solez K,Colvin R. Fibrosis and atrophy in the renal allograft:interim report and new directions[J]. Am J Transplant, 2002,2 (3) .. 203-206.
  • 4Solez K,Colvin RB,Raeusen LC, et al. Banff r05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (rCAN:) [J]. Am J Transplant, 2007,7 (3) .. 518-526.
  • 5Sis B, Mengel MM, Colvin RB, et al. Banff :09 MeetingReport : antibody mediated graft deterioration and imple- mentation of Banff working groups[J]. Am J Transplant, 2010,10 (3) ..464-471.
  • 6Anke S,Wilfried G, Markus H, et al. Safety and adequacy of renal transplant protocol biopsiesFJ:. Am J Trans- plant, 2005,5(8) : 1992-1996.
  • 7Patel MD, Phillips CJ, Young SW, et al. US-guided Renal Transplant Biopsy: Efficacy of a Cortical Tangential Ap- proach l[J]. Radiology,2010,256(1) :290-296.
  • 8Racusen LC,Colvin RB, Solez K, et al. Antibody mediated rejection criteria - an addition to the Banff 97 classifica- tion of renal allograft rejection [J]. Am J Transplant, 2003,3(6) :708-714.
  • 9Mondher O,Taher G,Samia B,et al. Acute tubular necro- sis in kidney transplantation[J]. Tunis Med,2012,90(6) .. 463-467.
  • 10Briganti EM,Russ GR,Mcneil JJ,et al. Risk of renal al- lograft loss from recurrent glomerulonephritisFJ]. N Engl J Med,2002,347(2) :103-109.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部